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for the Risk Assessment of 2,3,7,8-
Tetrachlorodibenzop-dioxin and Related
Compounds
by Stephen Safe
Polychlorinated biphenyls (PCBs),dibenzo-p-dioxins (PCDDs),dibenzofurans (PCDFs), andrelatedhaloge-
nated aromatic hydrocarbons (HAHs) are industrial compounds or by-products that have been identified as
contaminants inalmosteverycomponent oftheglobal ecosystem.2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)
is the most toxic HAH, and studies in rodents have shown that this compound is a carcinogen. Analysis of
environmental samples for HAHs has shown that these extracts contain complex mixtures of isomers and
congeners, and this greatly complicates risk assessment due to the paucity of data available for most ofthe
individual compounds. Extensive research has demonstrated a common receptor-mediated mechanism of
action for TCDD and related toxic HAHs, and this has led to the development of a mechanism-based risk
assessment approach for HAHs. Toxic equivalency factors (TEFs; relative potency compared to TCDD) have
been developed for selected HAH congeners, andthe TEF values can be used to determine "toxic equivalents"
(TEQs) for HAH mixtures. In addition, several bioassays that use receptor-mediated end points have been
developedandcanbeuseddirectlytodeterminetheTEQsforHAHmixtures. Theapplications oftheTEF/TEQ
approach for the risk assessment of HAHs are considerable, particularly with the conversion of complex
analytical data into TEQs. However, there appeartobe several limitations to this approach, particularly with
PCBs because their potential nonadditive (antagonistic), interactive effects with "2,3,7,8-TCDD-like" com-
pounds may invalidate the use ofthe risk assessment procedure for some environmental matrices.
Introduction
Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins
(PCDDs), and dibenzofurans (PCDFs) (Fig. 1) are haloge-
nated aromatic compounds that have been identified as
contaminants in almost every component of the global
ecosystemincludingtheair, aquaticandmarinesediments,
fish,wildlife and human adiposetissue, milk, andblood (1-
5). PCBs were widely used as industrial compounds and
have entered the enviromnent via numerous pathways
including direct leakage from industrial facilities or
machinery that used PCBs, leakage from waste sites
containing PCB fluids, accidents, and spills. In contrast,
PCDDs and PCDFs are industrial by-products that are
formed during the production of chlorinated phenols and
their derived products, PCBs and other chlorinated
organic compounds. PCDDs and PCDFs have also been
identified asby-products fromthecombustion ofmunicipal
and industrial waste, wood, coal, and numerous other
combustion processes. In addition, PCDDs and PCDFs
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FIGURE 1. Structures ofPCBs, PCDDs, and PCDFs.
are formed as by-products during the bleaching of wood
and pulp paper, and residues of these compounds have
been detected in pulp mill effluent and sludges, pulp
samples, finished paper products, and aquatic sediments
associated with discharges from pulp and paper mills
(1-7).
The structures of individual PCB, PCDD, and PCDF
congeners differ by their degree of chlorination and the
ringsubstitutionpatterns, andThble 1 illustratesthelarge
numberofpossible isomers and congeners forthese chem-
ical classes. There are 209 individual PCBs, and recent
high-resolution analytical studies (8) haveidentifled 132 ofS. SAFE
Table 1. Multiplicity ofPCB, PCDF, and PCDD isomers and congeners.
No. ofC1 atoms
1 2 3 4 5 6 7 8 9 10 Total
PCBs 3 12 24 42 46 42 24 12 3 1 209
PCDFs 4 16 28 38 28 16 4 1 - - 135
PCDDs 2 10 14 22 14 10 2 1 - - 75
these compounds in the commercial mixtures. The com-
position ofthe PCDD and PCDF by-products are highly
variable and dependent on their source. For example, the
PCDDs and PCDFs that have been identified as by-
products of combustion are complex mixtures of isomers
and congeners. Incontrast, thePCDDs andPCDFsfound
as contarrminants in many chlorinated phenol preparations
are less complex and dependent on the structures of the
chlorinated phenol precursors (7). Forexample, the highly
toxic 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is the
major contaminant identified in the herbicide 2,4,5-T or
Agent Orange (prepared from 2,4,5-trichlorophenol),
which was used as a defoliant in Vietnam. Nevertheless,
due to the diverse sources of PCDDs and PCDFs, most
extracts of environmental samples contain complex mix-
tures ofPCDDs, PCDFs, and PCBs.
Environmental Impact of PCBs,
PCDDs, and PCDFs
PCBs werefirstdetectedinthe environmentinthemid-
to late-1960s as unidentified peaks that were observed
duringthe gaschromatographic analysisofenvironmental
extracts for DDT and related metabolites and breakdown
products (9,10). Subsequent studies have identified PCBs
as residues in almost all environmental samples. Early
packed-column gas chromatographic analysis ofthe com-
mercialPCBsandPCBresiduesfromdiverseenvironmen-
tal extracts demonstrated the complex composition of
these mixtures (8-11); moreover, recent studies using
high-resolution analytical methods have confirmed that
commercial PCB mixtures and the PCB residues in
environmental extracts are highly complex. Inspection of
the chromatograms ofPCB residues from environmental
extracts andfromthecommercialmixturesclearlydemon-
strates thatthe congener composition ofthe extracts does
not resemble that of any single commercial PCB or their
reconstituted mixtures. PCBs associated with atmo-
spheric samples tend to contain some ofthe more volatile
lower-chlorinated congeners, whereas the PCB composi-
tion of extracts from water and sediment samples can be
highlyvariable anddepend, inpart, ontherelative rates of
microbial breakdown processes associated with these
environments (15-17).
Safe and co-workers (18) first reported that the domi-
nant PCB congeners (> 5%) in a composite human milk
sample from Michigan were 2,4,4'-trichlorobiphenyl,
2,4,4',5-tetrachlorobiphenyl, 2,3',4,4',5-pentachlorobiphenyl,
2,2',3,4,4',5'-hexachlorobiphenyl, 2,2',4,4',5,5'-hexa-
chlorobiphenyl, 2,2',3,3',4,4',5-heptachloiobiphenyl, and
2,2',3,4,4',5,5'-heptachlorobiphenyl. These compounds
constituted 58.9% of the total PCBs in the human milk
extract; however, at least 55 different PCBs were identi-
fied. Ruarte-Davidson andco-workers (19)reportedthata
similar set of PCB congeners were identified in human
tissue samples from several different locations, and many
of these same compounds are major PCB components in
wildlife samples. The differences in composition between
the PCBs in various environmental samples is no doubt
due to differential congener solubility, chemical and pho-
tochemical degradability, volatility, uptake, disposition,
and metabolism. Thus, although samples from the same
environmental matrix taken from different locations may
contain a similar set ofcongeners, their relative composi-
tion will be variable.
PCDDs and PCDFs have also been widely identified in
extracts ofenvironmental samples and the composition of
these analytes depend on their origins (e.g., air, water,
sediments, or biota) and inputs from nearby sources
(1,2,20,21). Several studies have reported the PCDD and
PCDF composition of atmospheric samples from both
urban industrial and rural areas (22-28). The absolute
concentrations ofthe sum ofPCDDs and PCDFs depend
onlocalorregionalinputs;however,thecongenerdistribu-
tion pattern for most atmospheric samples resembles a
typical combustion pattern for these compounds. Rappe
and co-workers (22,24) reported the PCDD and PCDF
content in several atmospheric particulate samples and
only slight variations were observed: for example, the E
PCDDs > XPCDFs; octachlorodibenzo-p-dioxin (OCDD)
andheptachlorodibenzo-p-dioxin (HpCDD)werethedom-
inant PCDDs with lower levels of the hexa-, penta-, and
tetrachlorodibenzo-p-dioxins (HCDD, PeCDD and
TCDD). In contrast, the tetra- and pentachlorodibenzo-
furans(TCDFandPeCDF)arethedominantPCDFswith
lower levels of the octa-, hepta-, and hexachlorodibenzo-
furans (OCDF, HpCDF, and HCDF). Similar patterns of
PCDD/PCDF distribution havebeen detected in soil sam-
ples (29) and on the outer surfaces ofpine needles, which
can be used as a biomonitor of atmospheric PCDDs,
PCDFs, PCBs, and related organic contaminants (30-32).
In contrast, only the 2,3,7,8-substituted PCDDs and
PCDFs are routinely detected in fish,wildlife, and human
samples (33-42).ThelevelsofPCDDsandPCDFsinbiotic
samples can vary depending on local contamination
sources. In general, the pattern of these compounds in
extracts from human samples resemble, in part, the com-
bustion and atmospheric pattern, with OCDD being the
dominant congener(Table2).Although theanalysis offish
samples also shows that only the 2,3,7,8-substituted com-
pounds are routinely detected, there is at least one major
difference in the congener distribution, namely, the low
levels of OCDD in fish extracts. OCDD is routinely
detected as a major component of aquatic and marine
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Congener
2,3,7,8-tetraCDD
1,2,3,7,8-pentaCDD
1,2,3,6,7,8-hexaCDD
1,2,3,7,8,9-hexaCDD
1,2,3,4,7,8-hexaCDD
1,2,3,4,6,7,8-heptaCDD
octaCDD
Fish samples from
Lake Michigan,
range (36)
3.0-4.4
7.0-12
4.1-10
0.5-1.3
0.5-1.2
0.7-1.1
0.8-1.2
U.S. EPA study,
mean ± SD (40)a
14.1 ± 10.9
18.9 ± 12.1
163.9 ± 106.7
18.0 ± 118
b
273.4 ± 248.4
1268 ± 1008
2,3,7,8-tetraCDF 31-39 2.1 ± 2.48
1,2,3,7,8-pentaCDF 3.9-8.0 0.6 ± 0.87
2,3,4,7,8-pentaCDF 8.1-14 23.0 ± 15.0
1,2,3,4,7,8-hexaCDF 0.9-2.4 21.4 ± 14.1
1,2,3,6,7,8-hexaCDF 0.7-1.9 10.9 ± 8.2
1,2,3,7,8,9-hexaCDF <0.08 0.33 ± 0.33
2,3,4,6,7,8-hexaCDF 0.3-4.0 3.3 ± 2.7
1,2,3,4,6,7,8-heptaCDF 0.5-1.7 36.5 ± 25.6
1,2,3,4,7,8,9-heptaCDF Not available 1.4 ± 1.2
octaCDF <6.7 3.1 ± 4.1
aAdipose tissue samples.
bGiven as a combined value of 1,2,3,6,7,8-hexaCDD/1,2,3,4,7,8-
hexaCDD.
sediments (43-45) and the low to nondetectable levels in
fish indicate that OCDD is not readily absorbed and/or
retained in fish tissue. In summary, it is evident that the
PCBs, PCDD, and PCDFs in the environment and human
tissues are present as complex mixtures of isomers and
congeners, andriskassessmentapproachesforthese com-
pounds must take into account this feature of congener
multiplicity.
Common Biochemical and Toxic
Responses and Mechanism of Action
Biochemical and Toxic Responses
Thebiochemicalandtoxic responses elicitedby commer-
cial PCBs, PCDDs, and PCDF mixtures and individual
congeners are somewhat variable and can depend on the
structure of the individual compound and the degree of
chlorination of the PCB mixture. However, it has been
demonstrated that specific mixtures and individual PCB,
PCDD, and PCDF congeners elicit a comparable spec-
trum of toxic and biochemical responses in laboratory
animals, humans, and mammalian cells in culture (6,46-
57). For example, the halogenated aromatic hydrocarbons
cause hepatotoxicity and porphyria, various endocrine
effects, tissue-specific hypo- and hyperplastic responses,
carcinogenic and anticarcinogenic effects, tumor promo-
tion activity,immunosuppressive effects, reproductive and
developmental toxicity, chloracne and related dermal
lesions, and bodyweight loss. The number ofbiochemical
responses caused by halogenated aryl hydrocarbons is
constantlygrowing. Initial studiesreported thatthis class
of chemicals induce both phase I and phase II drug-
metabolizing enzymes including aryl hydrocarbon hy-
droxylase (AHH), epoxide hydrolase, glucuronyl trans-
ferase, and glutathione S-transferase activities. In
addition, the induction ofseveral other responses, includ-
ing ornithine decarboxylase, DT diaphorase, epidermal
transglutaminase,aldehydedehydrogenase, and8-aminol-
evulinic acid synthetase have been reported. Halogenated
aromatics also decrease anumberofbiochemical activities
including the estrogen, progesterone, epidermal growth
factor, and glucocorticoid receptors, uroporphyrinogen
decarboxylase activity, thyroid hormone, and vitamin A
levels. The effects caused by halogenated aromatics are
also sex, age, species, and strain specific. For example,
chloracne and related dermal lesions are typical observed
in rabbits (ears), the skin of hairless mice, humans, and
monkeys but are not seen in other strains of mice, rats,
guineapigs, andhamsters.The reasonsforthedifferential
responsiveness of laboratory animals and mammalian
cells to halogenated aromatic hydrocarbons are not well
understood.
Mechanism ofAction ofHalogenated
Aromatic Hydrocarbon-Induced Responses
Poland and colleagues (58-60) and Thomas et al. (61)
first recognized the differential responsiveness ofseveral
different aromatic and halogenated aromatic hydrocarbon
congeners on the induction of hepatic microsomal AHH
activity in genetically inbred aryl hydrocarbon (Ah)
responsive and nonresponsive mice (typified by the
C57BL/6 and DBA strains, respectively) and their back-
crosses. Their results showed an approximately 10-fold
differenceinthe response ofthese strains totheinduction
ofAHH activity by2,3,7,8-TCDD. Based on their results,
it was proposed that the induction of AHH activity by
2,3,7,8-TCDD may be a receptor-mediated process and
that the decreased Ah-responsiveness ofDBA/2 mice was
due to a defect in the Ah receptor in this mouse strain.
Several studies with genetically inbred mice and their
backcrosses have shown that for PCDDs, PCBs, and
PCDFs, severaltoxic responsesincludingimmunotoxicity,
teratogenicity, bodyweight loss, hepatotoxicity, and por-
phyriasegregatewiththeAhlocus.Polandandco-workers
firstidentified the cytosolic Ah receptor in hepatic tissues
of C67BL/6 mice (62), and subsequent studies have con-
firmed the presence ofthis receptor in numerous animals,
organs, and mammalian cells in culture (63). The Ah
receptor is a high-affinity, low-capacity binding protein
that exhibits saturable binding with 2,3,7,8-TCDD and
other aromatic and halogenated aromatic hydrocarbons.
The results of numerous studies demonstrate that the
presence of the receptor is required for Ah responsive-
ness; however, there are many other factors that are also
involved in the regulation of PCB-, PCDD-, and PCDF-
induced responses. Nevertheless, the overall mechanism
illustrated in Figure 2 is generally accepted as a model
that describes themode ofaction ofthese compounds. The
molecular biology of2,3,7,8-TCDD-induced CYPlA1 gene
expression (i.e., the induction ofP4501Al-induced enzyme
activities such as AHH and ethoxyresorufin O-deethylase
[EROD]) has also beenextensivelyinvestigated (54,55,64-
71), and the results indicate that the nuclear Ah receptor
complex acts as aligand transcriptional factor (LTF) that
Table 2. Distribution ofPCDDs and PCDFs in
environmental extracts (ppt).
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FIGURE 2. Proposed receptor-mediated mechanism ofaction for 2,3,7,8-
TCDD and related compounds.
binds tospecificgenomicsitesinthe5'-regionflankingthe
CYPIAl gene (dioxin responsive elements, DREs) and
enhances gene transcription. This mechanism has been
well documented for only a few responses such as the
CYPlAl andglutathioneS-transferase Yagene(72); how-
ever, the target genes involved in the toxic responses
caused by this family ofchemicals are unknown.
Structure-Function Relationships. One of the hall-
marks of receptor-mediated responses is the unique
structure-receptor-binding relationships observedforthe
interactionsofstructurallydiverseligandswiththerecep-
tor. The structure-binding relationships for numerous
PCB,PCDD,andPCDFcongenershavebeendetermined,
and the results show that the most active congeners in
competitive Ah receptor binding assays are those com-
pounds substituted only in their lateral (2, 3, 7, and 8 for
thePCDDs andPCDFs;3,3',4,4', 5 and 5' forthePCBs)
positions (52,53,56,57). Figure 3 illustrates the structures
and competitive binding affinities ofthe most active con-
geners,whichareallapproximateisostereomers of2,3,7,8-
TCDD. The addition ofnonlateral chlorine substituent or
the removal oflateral chlorines tends to decrease the Ah
receptorbindingaffinitiesforthesecompounds. Forexam-
ple, themono-ortho coplanar PCB analogs exhibit 2,3,7,8-
TCDD-like activity; however, due to the addition of the
nonlateral ortho chlorine group, their potencies are sub-
stantially lower than the coplanar PCBs. It has also been
reported that there was arank-order correlation between
thestructure-binding andstructure-activityrelationships
for diverse Ah receptor-mediated responses in several
different species and inmammalian cellsin culture. These
observations supporttheproposedrole oftheAh receptor
in mediating the PCB, PCDD, and PCDF-induced
responses causedbythisfamilyofenvironmental contami-
nants and form the mechanistic basis forthe development
of the toxic equivalency factor (TEF) approach for the
hazard andriskassessment ofhalogenated arylhydrocar-
bon mixtures.
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FIGURE 3. Structures and AH receptor binding affinities of selected
toxic PCDD, PCDF, and PCB congeners.
Bradlaw and co-workers (73,74) first noted that the
induction ofAHH activity in rat hepatoma H-4II E cells
was apotentiallyusefuland sensitiveinvitrobioassayfor
toxic halogenated aryl hydrocarbons. Additional studies
by Safe and co-workers (52,56) have demonstrated that
there is a good correlation between the structure-
dependent AHH induction activities of individual PCB,
PCDD, and PCDF congeners in rat hepatoma H-4II E
cellsandtheirinvivo toxicpotenciesinrats andmice. For
example,Figures4and5illustratethecorrelationbetween
the in vitro AHH induction potencies of selected PCB,
PCDD, and PCDF congeners in rat hepatoma H-4II E
cellsandtheirinvivotoxicitiesintherat(6,56).Thesedata
confirm the utility of the in vitro induction assays as
short-term test systems for the quantitative analysis of
the toxicity of individual PCDD, PCB, and PCDF con-
geners and their mixtures. Moreover, these data and the
results ofnumerous other studies also provide the essen-
tial mechanistic-based framework for the development of
the TEF approach for the hazard and risk assessment of
these compounds (6).
Development of TEFs for PCBs,
PCDDs, and PCDFs
2,3,7,8-TCDD has generally been recognized as the
mosttoxic halogenated aryl hydrocarbon, and the toxicity
-of several PCB, PCDD, and PCDF congeners relative to
that of2,3,7,8-TCDD hasbeenreported (6). The resultsin
Table 3 summarize the range of relative potencies ofthe
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FIGURE 4. Correlation between the in vitro aryl hydrocarbon hydrox-
ylase induction potencies versus the in vivo toxicity (thymic atrophy in
therat) forseveral PCDD (@), PCDF (d), andPCB (0) congeners (6,56).
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FIGIJRE 5. Correlation between the in vitro aryl hydrocarbon hydrox-
ylase induction potencies versus the in vivo toxicity (bodyweight loss in
the rat) forseveral PCDD (@),PCDF (D), and PCB (0) congeners (6,56).
more highly toxic PCDD, PCDF, and PCB congeners,
which have been derived from numerous in vivo animal
studies andinvitrobioassays (6). Theresults demonstrate
that all ofthe compounds areless toxic than2,3,7,8-TCDD
and that for each congener there is a range of potencies
relative to that of2,3,7,8-TCDD. There is awide variation
in the range ofthese TEF values for different congeners,
and the variability ofthe TEFs depend on several factors
including the nature ofthe response, the animal or mam-
malian test system used, the route of exposure, and the
duration ofthe experiment. The relative pharmacokinetics
and metabolism of individual PCB, PCDD, and PCDF
Table 3. Relative range oftoxicities of PCB, PCDD, and PCDF
congeners compared to that of2,3,7,8-TCDD (6).
In vivo In vitro
Congener responses responses
2,3,7,8-tetraCDD 1.0 1.0
1,2,3,7,8-pentaCDD 0.59-0.053 0.64-0.07
1,2,3,6,7,8-hexaCDD 0.16-0.0152 0.5-0.005
1,2,3,7,8,9-hexaCDD 0.14-0.016 0.009
1,2,3,4,7,8-hexaCDD 0.24-0.013 0.13-0.015
1,2,3,4,6,7,8-heptaCDD 0.0076 0.003
octaCDD >0.0013 0.0006
2,3,7,8-tetraCDF 0.17-0.016 0.43-0.006
1,2,3,7,8-pentaCDF 0.9-0.018 0.13-0.003
2,3,4,7,8-pentaCDF 0.8-0.12 0.67-0.11
1,2,3,4,7,8-hexaCDF 0.18-0.038 0.2-0.013
1,2,3,6,7,8-hexaCDF - 0.48-0.037
1,2,3,7,8,9-hexaCDF
2,3,4,6,7,8-hexaCDF 0.097-0.017 0.1-0.015
1,2,3,4,6,7,8-heptaCDF 0.22
1,2,3,4,7,8,9-heptaCDF 0.20
octaCDF - -
3,3',4,4'-pentaCB 0.3-0.0006a
3,3',4,4'-tetraCB 0.009-0.00008a
3,3',4,4',5,5'-hexaCB 0.1-0.0012a
Mono-ortho coplaner PCBs 0.00045-0.0000014a
aIn vivo and in vitro.
congeners may depend on the strain, sex, age, and species
used and the target organ, and these factors no doubt
contribute to the wide range of potencies of these con-
geners relative to that of2,3,7,8-TCDD.
Nevertheless, several regulatory agencies have used
these data to develop TEFs for the 2,3,7,8-substituted
PCDDsandPCDFs(Table4),whichareroutinelydetected
asby-products ofindustrial andcombustionprocesses and
as residues in fish,wildlife, and human samples (75-79). A
conservative approach has been adopted for the selection
of most of the individual TEF values, with particular
emphasis on data obtained from long-term and reproduc-
tive studies. Safe (6) has also proposed a set of similar
TEFs for these compounds in which the value for the
1,2,3,4,6,7,8- and 1,2,3,4,7,8,9-HpCDFs was increased to
0.1 due to the result ofrecent studies on the immunosup-
pressive effects ofthe compounds in C57BL/6 mice. Reg-
ulatory agencies have not yet developed TEFs for the
2,3,7,8-TCDD-like PCB congeners; however, tentative
TEFvaluesforthecoplanarPCBs(Fig.2)andtheirmono-
and di-ortho-substituted analogs have also been proposed
(6).
Applications and Limitations of the
TEF Approach
One of the major applications of the TEF approach
involves the conversion of analytical data into toxic or
2,3,7,8-TCDD equivalents (TEQs) in which X (congener
concentration) x (congener TEF) = TEQs for that sam-
ple. For example, the results in Table 5 summarize the
TEQs for the PCB, PCDD, and PCDF components of
human milk fat extracts from Quebec, Canada (80). The
total TEQs for the PCDDs, PCDFs, and PCBs were 9.34,
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Table 4. Proposed toxic equivalents factors for the toxic
halogenated aromatics (6).
TEFs proposed by
Safe InternationaV Nordic
Congener (6) EPA (77,78) (76,79)-
PCDDs
2,3,7,8-tetraCDD 1.0 1.0 1.0
1,2,3,7,8-pentaCDD 0.5 0.5 0.5
1,2,3,6,7,8-hexaCDD 0.1 0.1 0.1
1,2,3,7,8,9-hexaCDD 0.1 0.1 0.1
1,2,3,4,7,8-hexaCDD 0.1 0.1 0.1
1,2,3,4,6,7,8-heptaCDD 0.01 0.01 0.01
octaCDD 0.001 0.001 0.001
PCDFs
2,3,7,8-tetraCDF 0.1 0.1 0.1
2,3,4,7,8-pentaCDF 0.5 0.5 0.5
1,2,3,7,8-pentaCDF 0.1 0.05 0.01
1,2,3,4,7,8-hexaCDF 0.1 0.1 0.1
2,3,4,6,7,8-hexaCDF 0.1 0.1 0.1
1,2,3,6,7,8-hexaCDF 0.1 0.1 0.1
1,2,3,7,8,9-hexaCDF 0.1 0.1 0.1
1,2,3,4,6,7,8-heptaCDF 0.1 0.01 0.01
1,2,3,4,7,8,9-heptaCDF 0.1 0.01 0.00
octaCDF 0.001
PCBs
3,3',4,4',5-pentaCB 0.1
3,3',4,4',5,5'-hexaCB 0.05
3,3',4,4'-tetraCB 0.01
Mono-ortho coplanar PCBs 0.001
Di-ortho coplanar PCBs 0.00002
Table 5. 2,3,7,8-TCDD equivalents (TEQs) in human adipose
tissue samples, Quebec, Canada (80).
Toxic Mean
equivalents concentration,
Congener factor ppt TEQs, ppt
2,3,7,8-tetraCDD 1.0 2.3 2.3
1,2,3,7,8-pentaCDD 0.5 4.8 2.4
1,2,3,4,7,8-hexaCDD 0.1 34 3.46 1,2,3,6,7,8-hexaCDD 0.1 36
1,2,3,7,8,9-hexaCDD 0.1 6.4 0.64
1,2,3,4,6,7,8-heptaCDD 0.01 40.5 0.41
octaCDD 0.001 131.7 0.13
Total
2,3,7,8-tetraCDF
1,2,3,7,8-pentaCDF
2,3,4,7,8-pentaCDF
1,2,3,4,7,8-hexaCDF
2,3,4,6,7,8-hexaCDF
1,2,3,6,7,8-hexaCDF
1,2,3,7,8,9-hexaCDF
1,2,3,4,6,7,8-heptaCDF
1,2,3,4,7,8,9-heptaCDF
octaCDF
Total
3,3',4,4',5-pentaCB
3,3',4,4',5,5'-hexaCB
3,3',4,4'-tetraCB
2,3,3',4,4'-pentaCB
2,3',4,4',5-pentaCB
2,3,3',4,4',5-hexaCB
Total
0.1
0.1
0.5
0.1
0.1
0.1
0.1
0.1
0.1
0.001
0.1
0.5
0.01
0.001
0.001
0.001
9.34
6.1 0.61
5.2 2.6
3.3 0.33
1.1 0.11
2.3 0.23
4.5 0.45
4.33
80.5
32.7
8.1
4400
17400
6.2
8.05
1.63
0.08
4.4
17.4
6.2
37.76
4.33, and 37.76 ppt, respectively, and the overall percent
contribution ofthese subclasses to the total TEQs in this
sample were 18.1, 8.4, and 73.5%, respectively. These
results are consistentwith datafrom several otherstudies
that indicate that the coplanar and mono-ortho coplanar
PCBs are major contributors to the total TEQs in fish,
wildlife, and human samples (81-86).
There is also evidence that the TEF approach can be
used topredictthetoxicityofPCDD andPCDF mixtures.
For example, Eadon and co-workers (87) tested the tox-
icity of an extract that contained a complex mixture of
PCDD andPCDF congeners.Thehigh-resolution analyti-
caldataforthesemixtureswasconvertedintoTEQsusing
theTEFfactorsandtheTEQsforthePCDDsandPCDFs
in the soot extract were 0.82 and 14.55 ppm, respectively.
In parallel experiments, the extract was administered to
guineapigs and compared to the toxicity of2,3,7,8-TCDD
for several responses including thymic atrophy, body
weight loss, increased serum triglycerides, decreased
serum alanine aminotransferase levels, the formation of
hepatocellular cytoplasmic inclusion bodies, and acute
lethality. The results showed that for the soot extracts,
ED50values derived forthese toxic responses from the in
vivo studies was 19, 21, 5, 18, 10, and 2 ppm, respectively,
with an average value of 12.5 ppm. The calculated TEQ
from the analytical data using the TEF approach was
15.37, and this value was remarkably similar to the TEQs
determined fromthe in vivo studies in guineapigs. These
data and results from other studies confirm the utility of
the TEF/TEQ approach for the hazard and risk assess-
ment ofPCDDs and PCDFs.
The use ofTEFs forthe hazard and risk assessment of
PCBs is also being considered as aregulatory tool forthe
hazard and risk assessment of PCBs (88). Structure-
function relationship studies for PCB isomers and con-
geners have demonstrated that the coplanar and
mono-ortho coplanar PCBs elicit 2,3,7,8-TCDD-like
responses. The development of TEF values (Table 4) for
these compounds is appropriate and should be useful for
the hazard and risk assessment of the total TEQs in
extracts of samples from environmental matrices. The
TEF values that have beenproposed for PCBs (6) maybe
highly conservative and should be confirmed or revised
based on ongoingresearch onthe toxicityofPCB isomers
and congeners. Davis and Safe (89) have determined the
dose-dependent immunosuppressive effects of several
commercial PCBs in C57BL/6 mice. The calculated TEQs
(from analytical data) for Aroclors 1260, 1254, 1248, and
1242 significantly overestimated (> 15-fold) the imnmu-
nosuppressiveeffects ofthesemixtures. Thus,theinterac-
tive effects ofthe 2,3,7,8-TCDD-like PCB congeners with
other PCB components of the mixture were not additive
and appeared to be antagonistic. These results are consis-
tent with the reported activity of individual PCBs and
PCB mixtures as 2,3,7,8-TCDD antagonists (89-92) and
suggest that the TEF approach may significantly over-
estimate the TEQs for environmental extracts containing
PCB, PCDD, andPCDF mixtures inwhich the concentra-
tions ofthePCBswere > 100-foldhigherthanthePCDDs
and PCDFs. Further studies are required to resolve this
important issue.
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Another major unresolved problem associated with the
TEF approach for PCBs is related to the potential bio-
chemical and toxic effects elicited by compounds that do
not act through the Ah receptor. For example, recent
studies have shown that a series of ortho-substituted
PCBs that do not exhibit 2,3,7,8-TCDD-like activity, are
neurotoxic in both rodent and monkey cells in culture
(93,94). These compounds, which typically contain two to
three ortho, zero to two para and low meta chlorine
substituents, decrease the dopamine content in brain
tissues and in mammalian cells. The adverse environmen-
tal and human health impacts ofthese more highly ortho-
substituted PCB congeners are unknown and require
further investigation.
A number of different structural classes ofPCBs also
induce P450 activities that are not mediated through the
Ah receptor (95,96). For example, several individual con-
geners, including 2,2',4,4'-tetraCB and 2,2',4,4',5,5'-
hexaCB have been characterized as pure phenobarbital
(PB)-type inducers and structure-induction studies sug-
gest that compounds substituted in at least two para and
twoortho substituentsinducethistype ofmonooxygenase
enzyme activity. The potential adverse health effects of
this class ofPCBs has notbeen determined; however, like
PB, these compounds cause hepatomegaly and exhibit
activity as potential tumor promoters in short-term bio-
assays for carcinogenesis. For example, 2,2',4,4',5,5'-
hexaCB promotes diethylnitrosamine-induced ATPase-
deficient lesions in rat liver (97,98). Because the previous
risk assessment ofPCBs has been derived, in part, from
carcinogenicity studies ofspecific PCB mixtures (99,100),
it is important not only to assess the contribution of all
structural classes of PCBs as carcinogens and anticar-
cinogens but also to determine whether PCB-induced
carcinogenicity is due to the activity ofthese compounds
as either promoters or initiators or a combination of the
two. Thus, although a limited TEF approach may be
warranted in some situations for assessing the risk ofAh
receptor-mediated responses, the application of this pro-
cedure forPCB-induced carcinogenic effects requires fur-
ther validation and more research.
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